一位老年老年医生大声说话
1Jerald Winakur (jwinakur@aol.com) is a retired geriatrician and an adjunct faculty member in the Division of Geriatric Medicine at UT Health-San Antonio, in Texas. His new book, Aging in America, will be published in 2026. Patient names in the essay have been changed for privacy.
Health affairs (Project Hope)
|March 2, 2026
概括
一位退休老年医生为美国老年人提供基本护理,这些老年人被医疗保健系统忽视了. 这凸显了老年人群专业老年医疗服务的严重缺口.
科学领域:
- 老年病的医生 老年病的医生
- 公共卫生 公共卫生
- 医疗保健的不平等 医疗保健的不平等
背景情况:
- 美国老龄化人口面临着独特的医疗保健挑战.
- 现有的医疗系统往往无法充分解决老年患者的复杂需求.
- 在专注于照顾老年人的专家方面存在明显的缺陷.
研究的目的:
- 检查退休老年医生在服务被忽视的患者群体中的作用.
- 确定美国老年人专业护理方面的差距.
- 倡导改善老年医疗保健服务.
主要方法:
- 一个退休老年医生实践的定性案例研究.
- 对患者病例示例的分析.
- 审查老年护理中的系统性障碍.
主要成果:
- 一位退休老年医生成功地为当前系统失败的患者提供护理.
- 对于专门的老年医疗服务,存在着大量未满足的需求.
- 通过专门的老年医疗护理,患者的治疗结果得到了改善.
结论:
- 退休老年医生可以在解决老年人的医疗保健缺口方面发挥重要作用.
- 医疗系统需要加强对老年人专业化的关注和资源.
- 需要改变政策和实践,以更好地服务美国老年人.
相关概念视频
Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacodynamics in Geriatric Patients: Effects of Age
288
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
288
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
766
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
766
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
277
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
277
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
303
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
303
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
292
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
292


